ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Chengcheng Wang
Matched on ORCID iD 0000-0002-1467-9267; OpenAlex author ID A5100389592. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper
Papers 7
- Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. Co-author DOI 10.1097/jp9.0000000000000175↗
- Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go First author DOI 10.1016/j.cgh.2023.08.022↗
- A commentary on 'The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study'. First author DOI 10.1097/js9.0000000000000588↗
- Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in … Co-author DOI 10.1186/s12885-022-09983-6↗
- Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.3389/fonc.2022.1004850↗
- Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Co-author DOI 10.1002/cac2.12204↗
- Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer. Co-author DOI 10.1186/s12935-021-01928-6↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruiyuan Xu · 6 shared papers, 2021–2024 · strength 1.17
- Paper Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go DOI 10.1016/j.cgh.2023.08.022↗
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Paper Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. DOI 10.3389/fonc.2022.1004850↗
- Yupei Zhao · 5 shared papers, 2021–2024 · strength 1.14
- Paper Early Detection of Pancreatic Cancer: Considerable Advances, but Still a Long Way to Go DOI 10.1016/j.cgh.2023.08.022↗
- Paper A commentary on 'The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a c… DOI 10.1097/js9.0000000000000588↗
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Yuan Chen · 4 shared papers, 2021–2024 · strength 0.83
- Paper A commentary on 'The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a c… DOI 10.1097/js9.0000000000000588↗
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Paper Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting … DOI 10.1186/s12885-022-09983-6↗
- Jianlu Song · 4 shared papers, 2021–2024 · strength 0.70
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Paper Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. DOI 10.3389/fonc.2022.1004850↗
- Paper Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting … DOI 10.1186/s12885-022-09983-6↗
- Rexiati Ruze · 4 shared papers, 2021–2024 · strength 0.70
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Paper Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. DOI 10.3389/fonc.2022.1004850↗
- Paper Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting … DOI 10.1186/s12885-022-09983-6↗
- Xinpeng Yin · 3 shared papers, 2022–2024 · strength 0.57
- Paper Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer. DOI 10.1097/jp9.0000000000000175↗
- Paper Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis. DOI 10.3389/fonc.2022.1004850↗
- Paper Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting … DOI 10.1186/s12885-022-09983-6↗
- Qiang Xu · 2 shared papers, 2022 · strength 0.34
- Jinshou Yang · 2 shared papers, 2021 · strength 0.29
- Lei You · 2 shared papers, 2021 · strength 0.29
- Jiangdong Qiu · 1 shared paper, 2021 · strength 0.16
- Bo Xu Ren · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.